CytRx Corporation reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was USD 13.18 million compared to USD 6.7 million a year ago. Basic loss per share from continuing operations was USD 0.35 compared to USD 0.19 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.76 USD | -4.83% | -3.16% | +112.31% |
May. 15 | LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 27 | LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+112.31% | 1.44M | |
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |
- Stock Market
- Equities
- LADX Stock
- News LadRx Corporation
- CytRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2021